Prifetrastat (PF-07248144), a first-in-class, selective, and orally active KAT6A and KAT6AB inhibitor. Prifetrastat can be used for the study of ER+/HER2- breast cancer[1].
Molecular Weight:
414.44
Purity:
99.63
CAS Number:
[2569008-99-5]
Formula:
C19H18N4O5S
Target:
Histone Acetyltransferase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted